The slip
PARKINSON RECEIPTno. 16580
31 Oct 2026, 20:26 UTCdopamine neurons, braak
predictionPRR5 in dopamine neurons tracks Braak Lewy-body stage
registered95d13377b0a0abcb
discovery-0.24 p=0.539 n=9
replication-0.42 p=0.258 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.24, p 0.539)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT97180253e88a6ad4df86ea48…
follows 5dcd0d7c05ae…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 16580: PRR5 in dopamine neurons, braak
- power
- full sample -0.35 (p 0.156, n 18), 95% CI -0.70 to +0.14. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.34 (p 0.161, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.38 (p 0.116, n 18). could be the mix.
- skeptic
- leave-one-out range -0.47 to -0.26, sign flips 0; without severely affected donors -0.35 (p 0.156, n 18). fragile.
- cell type
- strongest in microglia: -0.65 (p 0.0036, n 18) vs -0.35 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for PRR5 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up PRR5 · microglia · braak: substantia nigra, an independent cohort (already registered)